April 30, 2016 8:35 AM ET


Company Overview of VISCUM AG

Executive Profile

David R. Newell Ph.D.

Member of the Advisory Board, VISCUM AG
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships


Dr. David R. Newell, also known as Herbie, Ph.D. serves as Clinical Consultant of Astex Therapeutics Limited. Mr. Newell is a Professor of Cancer Therapeutics at the University of Newcastle Upon Tyne and Scientific Director of the Northern Institute for Cancer Research. He is a cancer pharmacologist and drug developer with over 30 years experience of the developing new treatments for adult and paediatric tumours. He serves as a Member of Scientific Advisory Board at ...

Corporate Headquarters

Bergisch-Gladbach, -- 51429


Phone: 49 2204 84 49 00
Fax: 49 2204 84 49 10

Board Members Memberships

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact VISCUM AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.